Medical/Pharmaceuticals

Everest Medicines Announces Strategic Collaboration with Medbanks Health Technology to Develop Innovative Healthcare Service Solutions for Patients in China

SHANGHAI, July 13, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater C...

2021-07-13 19:47 7552

Zepp Health Introduces Next Gen Smart Wearable Chip, Smartwatch OS and Blood Pressure Measurement at Annual Developers Conference

HEFEI, China, July 13, 2021 /PRNewswire/ -- Zepp Health Corp. (NYSE: ZEPP) today  hostedNext Beat 2021 – The Future of Heath, the company's annual developers conference, which included the announcement of several key company developments. Huangsha...

2021-07-13 19:41 17844

GenScript to Host Gene & Cell Engineering Virtual Summit

PISCATAWAY, N.J. , July 13, 2021 /PRNewswire/ -- GenScript® , the world's leading life science service provider, announced today the firstGenScript Gene & Cell Engineering Virtual Summit,

2021-07-13 19:30 49167

Nuctech™ Kylin Care Wins the German Red Dot Award, the "Oscar of the Design World"

BEIJING, July 12, 2021 /PRNewswire/ -- Recently, the German Red Dot Design Award, also known as the "Oscar of the design world", has been officially announced, and Nuctech has won the Red Dot: Best of the Best award, the top prize of Red Dot Award: Design Concept.

2021-07-13 11:30 2434

CD47 Monoclonal Antibody (AK117) Completed Phase I Dose Escalation Trial and Obtained Approval to Initiate Clinical Trial in Combination with Azacitidine for Treatment of Acute Myeloid Leukemia

HONG KONG, July 12, 2021 /PRNewswire/ -- Akeso, Inc. is pleased to announce that, CD47 monoclonal antibody (AK117), a second-generation novel drug for immuno-oncology therapy independently developed by the Company, has completed phase I dose escalation trial inAustralia. AK117 resulted in no dose...

2021-07-13 09:06 2610

Ascletis Announces Dosing of the First Cohort of Healthy Subjects in the FXR Agonist ASC42 Bridging Study for Chronic Hepatitis B Indication in China

--This bridging study to select doses for the Phase II trial in China in patients with chronic hepatitis B (CHB) --ASC42 clinical trials are being conducted in the U.S. and China for non-alcoholic steatohepatitis (NASH) and CHB. HANGZHOU and SHAOXING, China, July 13, 2021 /PRNewswire/ -- A...

2021-07-13 08:30 3875

Hochuen Medical Raises Tens of Millions RMB in Series A Financing

SHENZHEN, July 12, 2021 /PRNewswire/ -- Hochuen Medical Technology Co., Ltd. (hereinafter referred to as "Hochuen Medical") has raised a40 million Yuan (RMB) Series A round of financing led by Qiming Venture Partners as the sole investor. The new proceeds will be used to (1) accelerate the com...

2021-07-13 01:05 2365

Servier and Nymirum Announce Strategic Collaboration to Discover and Develop RNA-Targeted Small Molecule Therapeutics

PARIS, July 12, 2021 /PRNewswire/ -- Servier, a global independent pharmaceutical Group, and Nymirum, a pioneer in RNA-targeted small molecules, announced todaythat they have entered into a strategic collaboration to identify and develop RNA-modulatory drugs for the treatment of neurological ...

2021-07-12 23:00 1828

Werfen Companies Unite Under One Name And One Brand

BARCELONA, Spain, July 12, 2021 /PRNewswire/ -- Werfen today announced that its companies, including Instrumentation Laboratory (IL), Inova Diagnostics (Inova), and Biokit, are uniting under one name and one brand—Werfen. As part of this effort, the Company has completed organizational transition...

2021-07-12 20:00 2112

ProfoundBio Announces Completion of More Than $55 million Series A Financing to Advance Novel Antibody-Drug Conjugate (ADC) Portfolio

WOODINVILLE, Wash. and SUZHOU, China, July 12, 2021 /PRNewswire/ -- ProfoundBio announced the closing of a $55+ million Series A financing round led byLilly Asia Venture and co-led by LYFE Capital, with participation from Sequoia Capital China and Oriza.  All investors from the Series Pre-A finan...

2021-07-12 17:00 3463

Hummingbird Bioscience and MD Anderson Announce Strategic Research Collaboration To Advance Innovative Immunotherapies

HOUSTON and SINGAPORE, July 12, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to produce major improvements in treatment outcomes, andThe University of Texas MD Anderson Cancer Ce...

2021-07-12 17:00 1909

Stem cell therapy company Amniotics raises SEK 60 million before deduction of transaction costs, in First North IPO to advance lead candidate PulmoStem(TM) into clinic

Novel source of stem cells in full-term amniotic fluid provides basis for broad pipeline LUND, Sweden, July 12, 2021 /PRNewswire/ -- Amniotics AB (publ) ("Amniotics" or the "Company"), a stem cell therapy company has raisedSEK60 million through its recent listing on Nasdaq First North Growth Mar...

2021-07-12 14:00 3202

New Study Demonstrates Significantly Increased Healing Rates with NATROX® Oxygen Wound Therapy

Treatment offers hope for patients with long-standing chronic wounds CAMBRIDGE, England, July 12, 2021 /PRNewswire/ -- Inotec AMD, manufacturer of NATROX® Oxygen Wound Therapy, is delighted to share newly published randomised controlled trial (RCT) results[1]. The trial involved 145 patients with...

2021-07-12 13:00 1780

Everest Medicines Announces Strategic Commercial Partnership with Global Technology Company, Tencent

SHANGHAI, July 12, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater C...

2021-07-12 12:42 6004

LEAD Horizon: How Vienna gargles out of lockdown

VIENNA, July 12, 2021 /PRNewswire/ -- With the initiative "everything gargles" Vienna got through the pandemic better in comparison to other European cities. Every day, up to 70.000 people participate in the simple gargle PCR testing to inquire their Covid-19 status. Following the example ofVienn...

2021-07-12 08:30 3059

Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI323 (Anti-LAG-3/PD-L1 Bispecific Antibody) in Patients with Advanced Malignant Tumors

SAN FRANCISCO and SUZHOU, China, July 12, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...

2021-07-12 08:12 5393

Sciwind Biosciences Appoints Dr. Weidong Zhong as Chief Strategy Officer and President of its US Subsidiary

HANGZHOU, China and SAN FRANCISCO, July 12, 2021 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd., a clinical-stage, fast-growing biopharmaceutical company focusing on discovering and developing innovative therapies to treat chronic, metabolic and immunological diseases, announced today the...

2021-07-12 08:00 4057

Kintor Pharmaceutical Announced FDA Has Greenlighted Pyrilutamide's Phase II Clinical Trial for Androgenetic Alopecia in the US

SUZHOU, China, July 11, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX:9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has greenlighted pyrilutamide's phase...

2021-07-11 21:03 20502

HICOOL 2021 Global Entrepreneurship Competition (Preliminary Round) is Launched in Full Swing on July 10th

BEIJING, July 11, 2021 /PRNewswire/ -- On July 10th, HICOOL 2021 Global Entrepreneurship Competition (Qualifying Round) is launched in full swing. A total of 1,237 startups shortlisted for the preliminary round compete off-line inBeijing and online in a global context in six major industries: New...

2021-07-11 21:00 2443

Ortho Clinical Diagnostics' Quantitative COVID-19 IgG Antibody Test First to Receive FDA Emergency Use Authorization

- Ortho's new VITROS® Anti-SARS-CoV-2 IgG Quantitative Test targets the S1 spike protein and is calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies, which gives clinicians and public health leaders a standard tool to measure antibody response to SARS-CoV-2 - Ortho is ...

2021-07-10 03:33 30447